Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.75M Sell
52,194
-3,534
-6% -$333K 0.08% 206
2026
Q1
$6.59M Hold
55,728
0.18% 113
2025
Q4
$7.01M Buy
55,728
+6,999
+14% +$913K 0.18% 114
2025
Q3
$7.13M Buy
48,729
+3,608
+8% +$545K 0.18% 97
2025
Q2
$7.04M Buy
45,121
+3,246
+8% +$515K 0.21% 90
2025
Q1
$6.85M Sell
41,875
-3,373
-7% -$561K 0.22% 86
2024
Q4
$7.37M Buy
+45,248
New +$8.09M 0.22% 82

Other funds holding ZTS

Avanza Fonder's ZTS Position: Q2 2026 in Review

Avanza Fonder reduced its Zoetis (ZTS) stake by 6.3% in Q2 2026, selling an estimated $333K and leaving 52,194 shares worth $3.75M. The position accounts for 0.08% of the portfolio, ranked #206.

Avanza Fonder first reported a position in ZTS in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.37M in Q4 2024. 270 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Avanza Fonder held 52,194 shares of Zoetis worth $3.75M as of Q2 2026.
  • Avanza Fonder sold 3,534 Zoetis shares in Q2 2026, an estimated $333K.
  • Zoetis made up 0.08% of Avanza Fonder's portfolio in Q2 2026, its #206 holding.
  • Avanza Fonder first reported a position in Zoetis in Q4 2024 and has held it in 7 quarters since.
  • Avanza Fonder's Zoetis position peaked at $7.37M in Q4 2024.
  • 270 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.